KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $3.86.

  • Medpace Holdings' EPS (Weighted Average and Diluted) rose 2823.92% to $3.86 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3, marking a year-over-year increase of 2521.89%. This contributed to the annual value of $12.63 for FY2024, which is 4224.7% up from last year.
  • As of Q3 2025, Medpace Holdings' EPS (Weighted Average and Diluted) stood at $3.86, which was up 2823.92% from $3.1 recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' EPS (Weighted Average and Diluted) ranged from a high of $3.86 in Q3 2025 and a low of $1.06 during Q2 2021
  • For the 5-year period, Medpace Holdings' EPS (Weighted Average and Diluted) averaged around $2.33, with its median value being $2.22 (2023).
  • Examining YoY changes over the last 5 years, Medpace Holdings' EPS (Weighted Average and Diluted) showed a top increase of 6562.5% in 2021 and a maximum decrease of 149.25% in 2021.
  • Medpace Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at $1.32 in 2021, then surged by 59.09% to $2.1 in 2022, then rose by 17.14% to $2.46 in 2023, then soared by 48.59% to $3.66 in 2024, then rose by 5.6% to $3.86 in 2025.
  • Its EPS (Weighted Average and Diluted) was $3.86 in Q3 2025, compared to $3.1 in Q2 2025 and $3.67 in Q1 2025.